Clinical trial
Chemotherapy Toxicity Reduction Via Urea Cycle Support
NCT00223730 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00223730 |
|---|---|
| Title | Chemotherapy Toxicity Reduction Via Urea Cycle Support |
| Official title | Chemotherapy Toxicity Reduction Via Urea Cycle Support |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Citrulline, Placebo |
| Enrollment | 100 |
| Start date | Oct 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: